In one paragraphArticle in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Rodrigo Gutierrez-QuintanaSchool of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0002-3570-2542 Paul MontagueSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Angie RuppSchool of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0002-9413-0054 Niamh ByrneOban Vets, Oban PA34 5DD, United Kingdom.
Veronica Gonzalo-NadalSchool of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0009-0006-7721-5802 Ben AugustSchool of Medicine and Public Health, University of Wisconsin, Madison, WI 53705.
Margaret MullinSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Jennifer BarrieSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.
Julia M EdgarSchool of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.ORCID 0000-0002-3869-0962 Ian D Duncan *School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706.
Mark McLaughlin *School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.ORCID 0000-0001-5317-2090 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Pelizaeus-Merzbacher disease (PMD) is an X-linked hypomyelinating disorder caused by pathogenic variants in the proteolipid protein (
Indexed as
Dog DiseasesMutation, MissenseMyelin Proteolipid ProteinOligodendrogliaPelizaeus-Merzbacher DiseaseAnimalsDogsFemaleMaleMyelin SheathMyelin Proteolipid Proteinanimal modeldogleukodystrophyneurogeneticsprecision medicine
Identifiers
PMID41701830
PMCPMC12933053
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390